Dräger Atlan anesthesia workstations obtain Authority to Operate (ATO) under Risk Management Framework
Effective 7/14/2025 and expiring on 7/14/2028 under eMASS System ID #4060
TELFORD, Pa., Aug. 11, 2025 /PRNewswire/ -- Today Dräger, an international leader in medical and safety technologies, announced that the company's Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF) eMASS #4060.
"Cyberattacks continue to be a serious threat to hospitals – both clinically and financially," said President and CEO for Draeger, Inc., Lothar Thielen. "To help hospitals meet this challenge, Dräger embeds the latest cybersecurity technology deeply into our development processes. Our new Atlan anesthesia workstations now carry ATO certification, which is the highest level of security a medical device can hold."
Continuing a longstanding commitment to patient data securityCertification of Dräger's Atlan A350/A350XL anesthesia workstation follows the certifications of the Perseus A500 (eMASS # 2852) and Fabius MRI (eMASS # 2875) anesthesia workstations. Now with the Atlan certification, Dräger anesthesia customers can have confidence knowing that Dräger's entire anesthesia machine portfolio has gone through this rigorous cyber-security review process.
Benefits of ATO-certified medical devicesMedical devices that have achieved an Authority to Operate (ATO) under the Risk Management Framework (RMF) offer significant advantages to hospitals, including:
Enhanced security: Rigorous security assessments ensure that these devices meet high standards for protecting sensitive patient data and maintaining the integrity of medical operations
Compliance assurance: Devices that comply with federal regulations and standards reduce the risk of legal and regulatory issues
Reliability and trust: Hospitals can trust that these devices have been thoroughly vetted for security and performance, leading to greater confidence in their use in critical environments
Interoperability: Devices with ATO are often designed to integrate seamlessly with other systems within the healthcare network, enhancing overall efficiency and effectiveness
Continuous monitoring: Ongoing monitoring and updates continually address new security threats, ensuring that devices remain secure over time
Faster installation: ATO-certified devices streamline the process of integrating device data with electronic medical records, centralized alarm stations, and remote notifications
These benefits enable ATO-certified medical devices to provide stronger patient data protection and carry a lower risk of cyberattacks.
More information:Dräger Atlan A350/A350 XL family of devices:https://www.draeger.com/en-us_us/Products/Atlan-A350-US-Version
You can find more information and pictures in our press center:https://www.draeger.com/en-us_us/Newsroom/Press-Center
Dräger. Technology for Life.Dräger is a leading international medical and safety technology company. Our products protect, support and save lives. Founded in Lübeck, Germany in 1889, Dräger generated global sales of around EUR 3,4 billion in 2024. The Lübeck-based company is represented in more than 190 countries and employs more than 16,000 people worldwide. For more information, visit www.draeger.com
ContactCommunications: Melanie Kamann, Tel. +49 451 882-3202, melanie.kamann@draeger.com Press Contact North America: Laura Edwards, Tel. +1 215 565-5868, laura.edwards@draeger.com Investor Relations: Thomas Fischler, Tel. +49 451 882-2685, thomas.fischler@draeger.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/drager-atlan-anesthesia-workstations-obtain-authority-to-operate-ato-under-risk-management-framework-302526614.html
SOURCE Draeger
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
InventHelp Inventors Develop Mail Delivery Alert System (MBQ-699)
PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- "We thought there should be a convenient way to notify you when mail or other packages are delivered," said one of two inventors, from New York, N.Y., "so we invented the U MAIL. Our design allows you to retrieve delivered mail and packages quickly and without the hassle of repeated trips to the mailbox." The patent-pending invention provides an effective way to alert a homeowner of daily mail delivery. In doing so, it eliminates the need to guess when and if the mail has arrived. As a result, it increases security and convenience. It also provides added peace of mind. The invention features an automatic design that is easy to use so it is ideal for households, renters, and business owners. The original design was submitted to the Manhattan sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-MBQ-699, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp
Yahoo
2 hours ago
- Yahoo
InventHelp Inventors Develop Portable Food & Water Dish for Pets (LOS-350)
PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- "We thought there could be a better way to ensure your pet has access to food and water when out and about," said one of two inventors, from Eau Claire, Wisc., "so we invented the ON THE GO, SLOW FEED PET BOWL. Our design eliminates hassles when feeding your pet on-the-go or away from home." The invention provides a mobile means to ensure pets always have fresh, palatable food and water. In doing so, it can be used while walking, hiking, camping, traveling, visiting the beach or park, etc. As a result, it increases convenience, and it offers an alternative to traditional pet bowls. The invention features a portable design that is easy to use and transport so it is ideal for pet owners. Additionally, a prototype model and technical drawings are available upon request. The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-LOS-350, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Defibrillator Market worth US$16.44 billion by 2030 with 6.5% CAGR
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The global Defibrillator Market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. The growth in the defibrillator market is attributed to the increase in the prevalence of cardiovascular diseases, the increasing adult population with higher susceptibility to cardiac arrest, a strong focus of government organizations to enhance the accessibility of defibrillators by boosting the installation of public access defibrillators and providing training & programs on defibrillators. Additionally, the rapid expansion of healthcare infrastructure in emerging countries and strategic collaborations & partnerships among manufacturers to boost the new developments in defibrillators are likely to support the market's growth in the near future. Download PDF Brochure: Browse in-depth TOC on "Defibrillator Market" 337 - Tables57 - Figures296 - Pages By product, the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The implantable cardioverter defibrillators (ICDs) segment is anticipated to capture the largest global defibrillator market share by product in 2024. Timely intervention using implantable defibrillators during cardiac emergencies is a key advantage offered by this programmed device. Moreover, growing approvals of technologically advanced implantable defibrillators and rising preference for subcutaneous ICDs are likely to support the growth of this segment during the forecast period. By end users, the defibrillators market is segmented into Hospitals & Clinics, Cardiac Centers, Pre-hospital Settings, Public-Access Markets, Home Care Settings, and Other End Users. The hospitals & clinics segment dominated the global defibrillators market in 2024. The significant rise in hospitalization for critical cardiac conditions, the growing number of ICD and CRT-D implant procedures performed in hospitals, and the rising prevalence of cardiac diseases among geriatric patients are the major factors boosting the demand for defibrillators among target end-user segments during the study period. By geography, the defibrillator market is segmented based on the region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the defibrillator market. This can be attributed to the rapid adoption of technologically advanced defibrillators, favorable reimbursement policy, and the strong presence of manufacturers with a strong focus on strengthening R&D through investments in new product development. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to the presence of a large target patient pool, government initiatives to modernize & expand healthcare infrastructure, and expansion of market players in the region. Request Sample Pages : Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea). MEDTRONIC: MEDTRONIC Due to its extensive product portfolio, Medtronic is the leading player in the global implantable defibrillator market. The company primarily focuses on developing innovative products to treat and manage heart failure and heart rhythm disorders. The company focuses on inorganic business growth strategies such as product development & commercialization, acquisitions, and market expansions to strengthen its current position and gain a larger share of the neurovascular devices market. The company received the CE Mark for its implantable defibrillator systems, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan for managing irregular heart rhythms. Moreover, the company is also focusing on expanding its R&D capabilities to fuel product development and commercialization across mature and emerging markets. Koninklijke Philips N.V. Koninklijke Philips N.V. is a key player in the global defibrillator market, driven by its widely adopted HeartStart AED series. The company has established a strong presence through user-friendly, reliable devices designed for both public and professional use. Philips continues to lead with innovations such as real-time guidance, fast shock delivery, and connected care capabilities. Its strategic focus on accessibility, digital integration, and global deployment has reinforced its role in advancing out-of-hospital cardiac care. Boston Scientific Corporation Boston Scientific Corporation focuses on innovation and product launches in cardiac rhythm management to provide advanced solutions to healthcare professionals to improve the quality of life. The company continuously invests in R&D to launch new & innovative products. Boston Scientific primarily pursues the strategy of new product launches to sustain its position in the global defibrillators market. Regulatory approvals for its MRI-compatible defibrillators and technological advancements are expected to help the company maintain its position in the market. For more information, Inquire Now! Related Reports: Refurbished Medical Equipment Market IoT Medical Devices Market Cardiac Monitoring & Cardiac Rhythm Management Devices Market Respiratory Care Devices Market Top 10 Medical Device Technologies Market Get access to the latest updates on Defibrillator Companies and Defibrillator Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
